Adapting a combination approach to reduce heavy drinking and boost HIV care and prevention among young men
Official title: Adapting and Piloting a Combination Intervention to Reduce Heavy Drinking and Enhance HIV Treatment and Prevention Outcomes Among Young Men
Funded at University of California, San Diego · NIH-11621748 · Data updated 2026-11-12
A pilot project tests a proven program that helps young men cut down on heavy drinking and improves HIV treatment and prevention outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 20, 2026 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $72,230 |
| NIH project number | 3R34AA032499-01A1S1 |
| Project ID | NIH-11621748 on NIH RePORTER |
Who could benefit from this research
✓Could help
Young men in urban settings with or at risk for HIV who engage in high-risk drinking and have gaps in HIV care or prevention.
✕Less likely to help
Individuals who do not drink heavily or are already fully engaged in HIV care and prevention may see limited direct benefit.
What this research studies
This project will adapt Kisoboka, a multilevel intervention, for young men in an urban, upper-middle‑income setting to reduce risky alcohol use and improve engagement in HIV care and prevention. Researchers will use stakeholder interviews, focus groups, and theater testing to tailor materials, then pilot the adapted program with a small group of eligible participants. The study combines motivational interviewing, behavioral economics, and structural supports to address barriers to ART and PrEP adherence. The goal is to see if the adapted approach is feasible, acceptable, and shows promise for improving both alcohol use and HIV-related outcomes.
Why it matters
Potential benefit: If successful, participants may experience better adherence to HIV treatment and prevention strategies and reduced risky drinking.
How similar studies have gone: Prior Kisoboka work in Uganda showed promise; this study tests adaptation in a new setting, which could translate to broader use if effective.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Wynn, Adriane Michelle — University of California, San Diego
- Study coordinator: Wynn, Adriane Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.